Recent studies into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are demonstrating promising effects in addressing obesity and related 2 condition. Initial data suggest a distinct mechanism contributing https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/